Ranbaxy Laboratories plans to divest its investments in the group companies of Malvinder Singh and family. At the current market price, the value of these investments is a little over Rs 300 crore. The company will also sell its 13% stake in Orchid Chemical and Laboratories, which is worth about Rs 135 crore at the current market price.

Under the earlier management, Ranbaxy had picked up 4.45% stake in Fortis Healthcare and 25% stake in Shimal Research Laboratories. At current price of Rs 163 per share, Ranbaxy’s stake in Fortis Healthcare is valued at Rs 230 crore. crackcrack
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×